Inventor
TIBBITTS THOMAS T
US22 patents
⚠️ This page may combine multiple inventors who share the name “TIBBITTS THOMAS T”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
INFINITY PHARMACEUTICALS INC
7 patentsUS8349814B2Jan 8, 2013
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC3 citations74
US7947663B2May 24, 2011
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC6 citations74
US9108989B2Aug 18, 2015
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC1 citations63
US8629125B2Jan 14, 2014
Inhibitors of fatty acid amide hydrolase
INFINITY PHARMACEUTICALS INC3 citations63
US9346769B2May 24, 2016
Tetrazolones as inhibitors of fatty acid synthase
INFINITY PHARMACEUTICALS INC2 citations61
US7842815B2Nov 30, 2010
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
INFINITY PHARMACEUTICALS INC5 citations61
US9630979B2Apr 25, 2017
Inhibitors of monoacylglycerol lipase and methods of their use
INFINITY PHARMACEUTICALS INC0 citations52
BEHNKE MARK L
4 patentsUS9149465B2Oct 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations49
US8765735B2Jul 1, 2014
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L1 citations49
US8957049B2Feb 17, 2015
Inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations39
US8927551B2Jan 6, 2015
Isoxazolines as inhibitors of fatty acid amide hydrolase
BEHNKE MARK L0 citations39
CASTRO ALFREDO C
3 patentsUS8609706B2Dec 17, 2013
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51
US8461191B2Jun 11, 2013
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C1 citations51
US8178690B2May 15, 2012
Compounds and methods for inhibiting the interaction of BCL proteins with binding partners
CASTRO ALFREDO C0 citations51